Showing results (1611-1620 of 1,645) with videos related to

Sort By:
Pageof 165
Rice (New York, N.Y.)|October 3, 2025
Natural variation of the MIR168a promoter influences its activity and miR168a abundance in riceZhi-Xue Zhao, Xiu-Lian Yan, Rong Liao, et al.
Plos One|March 11, 2014
Characterization of defects in ion transport and tissue development in cystic fibrosis transmembrane conductance regulator (CFTR)-knockout ratsKatherine L Tuggle, Susan E Birket, Xiaoxia Cui, et al.
NPJ Digital Medicine|July 15, 2026
Explainable machine learning for 10-year prediction of cognitive impairment in a rural Chinese populationBotang Guo, Shiqi Li, Minyao Li, et al.
Signal Transduction and Targeted Therapy|September 18, 2020
Novel insights into stress-induced susceptibility to influenza: corticosterone impacts interferon-β responses by Mfn2-mediated ubiquitin degradation of MAVSZhuo Luo, Li-Fang Liu, Ying-Nan Jiang, et al.
American Journal of Respiratory and Critical Care Medicine|September 18, 2013
Cigarette smoke induces systemic defects in cystic fibrosis transmembrane conductance regulator functionS Vamsee Raju, Patricia L Jackson, Clifford A Courville, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|June 1, 2010
[Identification of the active material of anti-hepatic fibrosis from Amydae Carapax]Jian-rong Gao, Yan-wen Liu, Chang-yu Li, et al.
Lancet (London, England)|April 21, 2024
Matching actions to needs: shifting policy responses to the changing health needs of Chinese children and adolescentsTian-Jiao Chen, Bin Dong, Yanhui Dong, et al.
Clinical and Translational Gastroenterology|May 26, 2023
Efficacy and Safety of Keverprazan Compared With Lansoprazole in the Treatment of Duodenal Ulcer: A Phase III, Randomized, Double-Blind, Multicenter TrialNian-di Tan, Xin-Pu Miao, Ai-Jun Liao, et al.
Biorxiv : the Preprint Server for Biology|January 23, 2024
Targeting transcription factors through an IMiD independent zinc finger domainBee Hui Liu, Miao Liu, Sridhar Radhakrishnan, et al.
Influenza and Other Respiratory Viruses|July 28, 2023
Safety and efficacy of AK0529 in respiratory syncytial virus-infected infant patients: A phase 2 proof-of-concept trialLi-Min Huang, Andreas Schibler, Yi-Chuan Huang, et al.
Pageof 165